ES2056872T3 - Proteina pp4-x anticoagulante, su preparacion y empleo. - Google Patents

Proteina pp4-x anticoagulante, su preparacion y empleo.

Info

Publication number
ES2056872T3
ES2056872T3 ES88118038T ES88118038T ES2056872T3 ES 2056872 T3 ES2056872 T3 ES 2056872T3 ES 88118038 T ES88118038 T ES 88118038T ES 88118038 T ES88118038 T ES 88118038T ES 2056872 T3 ES2056872 T3 ES 2056872T3
Authority
ES
Spain
Prior art keywords
preparation
anticoagulant protein
protein
anticoagulant
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88118038T
Other languages
English (en)
Inventor
Ulrich Dr Grundmann
Karl-Josef Dr Abel
Egon Dr Amann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Application granted granted Critical
Publication of ES2056872T3 publication Critical patent/ES2056872T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721—Lipocortins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/851—Placenta; amniotic fluid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

LA PROTEINA PP4 - X SE DETERMINA SU SECUENCIA AMINOACIDICA Y LA SECUENCIA DE DNA CODIFICADO DE AQUELLA, TIENE CARACTER ANTICOAGULANTE Y SE PUEDE OBTENER GENETICAMENTE, PP4 - X TIENE UTILIZACION CON OBJETO DIAGNOSTICO Y TERAPEUTICO.
ES88118038T 1987-11-03 1988-10-29 Proteina pp4-x anticoagulante, su preparacion y empleo. Expired - Lifetime ES2056872T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873737237 DE3737237A1 (de) 1987-11-03 1987-11-03 Anticoagulatorisches protein pp4-x, seine herstellung und verwendung

Publications (1)

Publication Number Publication Date
ES2056872T3 true ES2056872T3 (es) 1994-10-16

Family

ID=6339663

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88118038T Expired - Lifetime ES2056872T3 (es) 1987-11-03 1988-10-29 Proteina pp4-x anticoagulante, su preparacion y empleo.

Country Status (11)

Country Link
US (1) US5202419A (es)
EP (1) EP0315081B1 (es)
JP (1) JPH01165387A (es)
KR (1) KR890008316A (es)
AT (1) ATE109509T1 (es)
AU (1) AU613676B2 (es)
DE (2) DE3737237A1 (es)
DK (1) DK610488A (es)
ES (1) ES2056872T3 (es)
FI (1) FI885025A (es)
PT (1) PT88913B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2096556T3 (es) * 1988-02-26 1997-03-16 Biogen Inc Secuencias de adn, moleculas de adn recombinante y procedimientos para producir lipocortinas iii, iv, v y vi.
DE3939169A1 (de) * 1989-11-27 1991-05-29 Behringwerke Ag Verfahren zur reinigung von lipocortinen
DE4012341A1 (de) * 1990-04-18 1991-10-24 Behringwerke Ag Monoklonale antikoerper gegen pp4, verfahren zu ihrer herstellung und ihre verwendung
US20030220233A1 (en) 1994-01-24 2003-11-27 Neorx Corporation Radiolabeled annexins
US5968477A (en) * 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3315000A1 (de) * 1983-04-26 1984-10-31 Behringwerke Ag, 3550 Marburg Gewebeprotein pp(pfeil abwaerts)4(pfeil abwaerts), verfahren zu seiner gewinnung sowie seine verwendung
ATE108830T1 (de) * 1985-01-10 1994-08-15 Biogen Inc Dns-sequenzen, rekombinante dns-moleküle und verfahren zur herstellung menschlicher lipocortinähnlicher polypeptide.
CA1265446A (en) * 1985-09-30 1990-02-06 Masahiro Maki Anticoagulating substance, process for preparing same and anticoagulant comprising same as an effective component
US4937324A (en) * 1987-02-06 1990-06-26 Zymogenetics, Inc. Chromatographic purification of human proteins having anticoagulant and anti-inflammatory activity
WO1988005659A1 (en) * 1987-02-06 1988-08-11 Zymogenetics, Inc. Human proteins having anticoagulant and anti-inflammatory activity

Also Published As

Publication number Publication date
EP0315081A2 (de) 1989-05-10
DK610488A (da) 1989-05-04
FI885025A (fi) 1989-05-04
EP0315081A3 (en) 1990-05-30
EP0315081B1 (de) 1994-08-03
AU613676B2 (en) 1991-08-08
FI885025A0 (fi) 1988-11-01
PT88913B (pt) 1993-01-29
US5202419A (en) 1993-04-13
DK610488D0 (da) 1988-11-02
AU2459188A (en) 1989-05-04
KR890008316A (ko) 1989-07-10
PT88913A (pt) 1988-12-01
JPH01165387A (ja) 1989-06-29
DE3737237A1 (de) 1989-05-18
ATE109509T1 (de) 1994-08-15
DE3850933D1 (de) 1994-09-08

Similar Documents

Publication Publication Date Title
NO871409D0 (no) Fusjonsprotein.
DE3586313D1 (de) Konjugate von pharmazeutisch nuetzlichen proteinen.
DE3884803D1 (de) Gold-kompressionsverbindung.
DE3851238D1 (de) Antikoagulierende Peptide.
DK555088A (da) Blodtagningsventil
DK161775C (da) Fastgoerelsesorgan til cylinderlaase
NO881658L (no) Biofunksjonelle proteiner.
NO882226L (no) Fibrinolytiske proteiner.
DE3872754D1 (de) Nachweis von antikoerpern humaner immundefizienz-viren.
DE3783966T2 (de) Reagens zur pruefung von periodentalen erkrankungen.
DE3883439T2 (de) Bestimmung von Peptidsequenzen.
NO873216L (no) Rekombinante htlv-iii-proteiner og anvendelse derav.
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
PT86678A (pt) Protein extract
ES2056872T3 (es) Proteina pp4-x anticoagulante, su preparacion y empleo.
DK345087D0 (da) Protein
NO881502L (no) Rekombinante htlv-111-proteiner og anvendelser av disse.
DE3872790T2 (de) Geraet zur untersuchung von reissverschlusselementen.
DK295588A (da) Hiv-gag kodede proteiner
DK193189A (da) Hiv-beslaegtede polypeptider, diagnostiske systemer og analysemetoder
DE3885735T2 (de) Von einem lebenden körper abgeleitetes protein.
NO173340C (no) Humant protein C antistoff
NO875477D0 (no) Rekombinant alveolaert overflateaktivt protein.
DK694287D0 (da) Overfladeaktivt rekombinant-alveolaerprotein
LV10393A (lv) Savietojams cilveka olbaltumvielas preparats

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 315081

Country of ref document: ES